Age-related distribution of human papillomavirus genotypes in women with cervical squamous cell carcinoma from Linyi, China, 2015-2023
- PMID: 40405259
- PMCID: PMC12100862
- DOI: 10.1186/s12985-025-02790-y
Age-related distribution of human papillomavirus genotypes in women with cervical squamous cell carcinoma from Linyi, China, 2015-2023
Abstract
Background: Understanding the regional HPV genotype profile is critical for informing targeted vaccination strategies and optimizing cervical cancer screening programs to enhance their effectiveness. This study investigated the prevalence and distribution of human papillomavirus (HPV) genotypes among women with cervical squamous cell carcinoma (CSCC) in Linyi city, China, from 2015 to 2023.
Methods: Data were obtained from 606 women histologically diagnosed with CSCC at Linyi Cancer Hospital between January 2015 and December 2023. DNA was extracted from paraffin-embedded tissue samples. HPV genotyping was performed via gene chip-based polymerase chain reaction (PCR) technology. Temporal trends and age-specific variations in HPV genotype distribution were analyzed to provide a comprehensive epidemiological assessment.
Results: The overall prevalence of HPV infection was 94.7% among 606 women with CSCC. HPV 16 was the most prevalent genotype (80.5%), followed by HPV 18 (5.2%), HPV 33 (2.8%), HPV 31 (1.8%), and HPV 58 (1.8%). Single infections were predominant (95.5%), while coinfections were observed in 4.5% of the cases. Age-specific analysis revealed that non-HPV 16 infections were more prevalent in women aged > 45 years, with greater genotype diversity in older age groups. Temporal trends indicated a decline in the prevalence of younger CSCC patients (26-45 years), whereas the prevalence of older women significantly increased.
Conclusion: Our study revealed that HPV genotype diversity in CSCC patients varies with age, highlighting the need for age-stratified and personalized cervical cancer prevention strategies. Enhanced screening efforts for older women are essential because of the greater genotypes diversity in this group. Additionally, the observed trends in HPV prevalence over time suggest that HPV vaccination has effectively reduced the incidence of CSCC in women under 45 years of age. These findings emphasize the importance of expanding vaccination coverage and optimizing screening programs to further reduce the cervical cancer burden across different age groups.
Keywords: Age; Cervical squamous cell carcinoma; China; HPV genotypes; Human papillomavirus; Prevalence.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study followed the ethical guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of Nanjing Chinese Medicine Hospital, China. Consent for publication: All of the patients signed an informed consent form. Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Investigation and analysis of female HPV infection and genotype distribution in Xuhui District, Shanghai.Virol J. 2025 Mar 5;22(1):59. doi: 10.1186/s12985-025-02663-4. Virol J. 2025. PMID: 40045415 Free PMC article.
-
Genotype distribution of human papillomavirus among women with cervical cancer stratified by HIV status in Tanzania.PLoS One. 2025 Aug 1;20(8):e0322311. doi: 10.1371/journal.pone.0322311. eCollection 2025. PLoS One. 2025. PMID: 40748896 Free PMC article.
-
Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.PLoS One. 2015 Apr 14;10(4):e0122488. doi: 10.1371/journal.pone.0122488. eCollection 2015. PLoS One. 2015. PMID: 25875167 Free PMC article.
-
Characterization of human papillomavirus genotypes infections in patients with cervical lesions and cervical cancer in Urumqi, Xinjiang from 2016 to 2023.Virol J. 2025 Mar 13;22(1):72. doi: 10.1186/s12985-025-02674-1. Virol J. 2025. PMID: 40082961 Free PMC article.
-
Human papillomavirus (HPV) genotype distribution in Malaysia: A systematic review.BMC Infect Dis. 2025 Aug 10;25(1):1010. doi: 10.1186/s12879-025-11441-0. BMC Infect Dis. 2025. PMID: 40784935 Free PMC article.
Cited by
-
Multiple high-risk human papillomavirus infections exacerbate cervical lesion risk: epidemiological evidence from suining, Sichuan.Virol J. 2025 Aug 5;22(1):268. doi: 10.1186/s12985-025-02904-6. Virol J. 2025. PMID: 40764564 Free PMC article.
References
-
- Yuan Y, Cai X, Shen F, Ma F. HPV post-infection microenvironment and cervical cancer. Cancer Lett. 2021;497:243–54. - PubMed
-
- Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical